Is Alpha Teknova, Inc. (TKNO) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 26.7% / 30% | 26.9% / 30% | 3.8% / 30% | 0.0% / 5% | ✓ HALAL |
| DJIM | 26.7% / 33% | 26.9% / 33% | 3.8% / 33% | 0.0% / 5% | ✓ HALAL |
| MSCI | 25.4% / 33% | 25.6% / 33% | 3.6% / 33% | 0.0% / 5% | ✓ HALAL |
| S&P | 26.7% / 33% | 26.9% / 33% | 3.8% / 33% | 0.0% / 5% | ✓ HALAL |
| FTSE | 25.4% / 33% | 25.6% / 33% | 3.6% / 50% | 0.0% / 5% | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 33.2% | |
| Operating Margin | -41.2% | |
| Net Margin | -42.6% | |
| Return on Equity (ROE) | -22.8% | |
| Return on Assets (ROA) | -9.3% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$9M |
| Free Cash Flow | -$10M |
| Total Debt | $28M |
| Debt-to-Equity | 41.1 |
| Current Ratio | 4.6 |
| Total Assets | $104M |
Price & Trading
| Last Close | $2.83 |
| 50-Day MA | $2.59 |
| 200-Day MA | $4.24 |
| Avg Volume | 251K |
| Beta | 0.4 |
|
52-Week Range
$1.91
| |
About Alpha Teknova, Inc. (TKNO)
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Alpha Teknova, Inc. (TKNO) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Alpha Teknova, Inc. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Alpha Teknova, Inc.'s debt ratio?
Alpha Teknova, Inc.'s debt ratio is 26.7% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 25.4%.
What are Alpha Teknova, Inc.'s key financial metrics?
Alpha Teknova, Inc. has a market capitalization of $145M, and revenue of $41M. The company maintains a gross margin of 33.2% and a net margin of -42.6%. Return on equity stands at -22.8%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.